_________________________________________________________________
Medical Cannabis Information
Relative Safety of Medical Marijuana
Dr. Harold Kalant, Professor Emeritus of Pharmacology at the University of Toronto is an expert witness in courts and he has testified: "Studies and anecdotal histories also suggest that THC works to relieve pain and muscle spasms. Cannabinoids in general are good analgesics. According to Dr. Kalant, there have been no recorded deaths from the consumption of marihuana alone. Consumption of marihuana is relatively harmless compared to the so-called hard drugs and including tobacco and alcohol and there is no "hard evidence" that even longterm use can lead to irreversible physical or psychological damage." R. v. Krieger, 2000
_________________________
"Marijuana is the safest therapeutically active substance known to man... safer than many foods we commonly consume." DEA Judge Francis L. Young, Sept. 6, 1988
____________________________
"After carefully monitoring the literature for more than two decades, we have concluded that the only well-confirmed deleterious physical effect of marihuana is harm to the pulmonary system." Grinspoon M.D., James B. Bakalar
____________________________
Medical Marijuana has been in use for thousands of years, and in spite of substantial efforts to find adverse effects, it remains the safest medication available for RBS (Racing Brain Syndrome). There has never been a single known case of lethal overdose. The ratio of lethal to effective dose for medical marijuana is estimated to be as 40,000 to 1. By comparison, the ratio is 3-50 to 1 for secobarbital and 4-10 to 1 for alcohol.(11)
_________________________________
Therapeutic Uses of Marijuana
_________________________________
US Patent 6630507
Cannabinoids as antioxidants and neuroprotectants
The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Non-psychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.
Claim:
1. A method of treating diseases caused by oxidative stress, comprising administering a therapeutically effective amount of a cannabinoid that has substantially no binding to the NMDA receptor to a subject who has a disease caused by oxidative stress.
______________________________
Medical Marijuana in the Workplace
a diagnosis for employers
By Richard J. Charney Contributor
Labour and employment senior law partner, Norton Rose Fulbright Canada LLP
The number of licences granted to possess medical marijuana in Canada more than doubled in 2012, from under 14,000 in January to over 28,000 in December. Upcoming changes to the way it is approved suggest these numbers will continue to grow.
The use of prescribed marijuana by employees creates new questions for Canadian employers. How do you deal with an employee in a safety-sensitive role who has a medical marijuana licence? Are employees with medical marijuana licences exempt from drug testing? If an employee with a licence says they need to use their marijuana at the workplace, how is this addressed?
cannabis doctors, prescription marijuana, prescription cannabis, cannabis canada, doctors canada, licensed cannabis, cannabis producers
